Portfolio company
Miroculus
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Miroculus develops digital microfluidics platforms that automate genomic protocols and sample preparation for scientists in academic, research and diagnostic laboratories.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Dropworks
This company develops digital PCR instruments for highly sensitive nucleic acid quantification for life science and diagnostic researchers.
Inso Bio
Inso Bio develops automated microfluidic platforms for genomic sample preparation to serve researchers, clinicians, and biotechnology laboratories.
Hologenomix
Hologenomix develops an extraction platform for isolating cell-free nucleic acids from biofluids to provide liquid biopsy and molecular diagnostic services to research and healthcare institutions.
DropCode
This company develops a droplet-microfluidics platform and DNA barcoding to provide protein analysis data for biotechnology and pharmaceutical organisations.
Genomill Health
Genomill Health develops targeted sequencing technology for liquid biopsies to assist clinical laboratories and pharmaceutical companies with precision cancer diagnostics.
Lightcast Discovery
Lightcast Discovery develops a microfluidic platform using light to manipulate droplets for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Medra
Medra develops an autonomous robotic platform that designs and executes laboratory protocols for scientists in fields such as genomics and biochemistry.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
